Type 2 Inflammation Modulates ACE2 and TMPRSS2 in Airway Epithelial Cells

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 2020 May 19

PMID 32422146

Citations 176

Authors

Hiroki Kimura

Dave Francisco

Michelle Conway

Fernando D Martinez

Donata Vercelli

Francesca Polverino

Dean Billheimer

Monica Kraft

Affiliations

Soon will be listed here.

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has dramatically changed our world, country, communities, and families. There is controversy regarding risk factors for severe COVID-19 disease. It has been suggested that asthma and allergy are not highly represented as comorbid conditions associated with COVID-19.

Objective: Our aim was to extend our work in IL-13 biology to determine whether airway epithelial cell expression of 2 key mediators critical for SARS-CoV-2 infection, namely, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2), are modulated by IL-13.

Methods: We determined effects of IL-13 treatment on ACE2 and TMPRSS2 expression ex vivo in primary airway epithelial cells from participants with and without type 2 asthma obtained by bronchoscopy. We also examined expression of ACE2 and TMPRSS2 in 2 data sets containing gene expression data from nasal and airway epithelial cells from children and adults with asthma and allergic rhinitis.

Results: IL-13 significantly reduced ACE2 and increased TMPRSS2 expression ex vivo in airway epithelial cells. In 2 independent data sets, ACE2 expression was significantly reduced and TMPRSS2 expression was significantly increased in the nasal and airway epithelial cells in type 2 asthma and allergic rhinitis. ACE2 expression was significantly negatively associated with type 2 cytokines, whereas TMPRSS2 expression was significantly positively associated with type 2 cytokines.

Conclusion: IL-13 modulates ACE2 and TMPRSS2 expression in airway epithelial cells in asthma and atopy. This deserves further study with regard to any effects that asthma and atopy may render in the setting of COVID-19 infection.

Citing Articles

Exploring Asthma as a Protective Factor in COVID-19 Outcomes.

Quinn A, Zhao L, Bell S, Huq M, Fang Y Int J Mol Sci. 2025; 26(4).

PMID: 40004141 PMC: 11855143. DOI: 10.3390/ijms26041678.

Impact of SARS-CoV-2 on the male reproductive tract: insights from semen analysis and cryopreservation.

Giugliano S, Mozzarelli A, Navarra A, De Simone G, Rescigno M, Levi-Setti P J Assist Reprod Genet. 2024; 42(2):577-587.

PMID: 39699717 PMC: 11871218. DOI: 10.1007/s10815-024-03321-4.

Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the Pandemic.

Isono T, Kojima A, Nishida T, Kobayashi Y, Ishiguro T, Takaku Y Intern Med. 2024; 64(3):367-374.

PMID: 39566990 PMC: 11867742. DOI: 10.2169/internalmedicine.4276-24.

Asthma as a risk factor and allergic rhinitis as a protective factor for COVID-19 severity: a case-control study.

Lira Tenorio M, Dos Santos Menezes Siqueira G, Caldas G, Pacheco de Almeida R, de Jesus A, Martins-Filho P Eur Arch Otorhinolaryngol. 2024; 281(12):6677-6686.

PMID: 39180537 DOI: 10.1007/s00405-024-08893-6.

Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19.

Dong J, Su D, Zhao B, Han J, Tu M, Zhang K Curr Issues Mol Biol. 2024; 46(7):6633-6645.

PMID: 39057037 PMC: 11275266. DOI: 10.3390/cimb46070395.

References

Kraft M, Adler K, Ingram J, Crews A, Atkinson T, Cairns C . Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J. 2008; 31(1):43-6. DOI: 10.1183/09031936.00103307. View

Batlle D, Wysocki J, Satchell K . Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?. Clin Sci (Lond). 2020; 134(5):543-545. DOI: 10.1042/CS20200163. View

Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

Balakumar P, Jagadeesh G . A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cell Signal. 2014; 26(10):2147-60. DOI: 10.1016/j.cellsig.2014.06.011. View

Wosten-van Asperen R, Lutter R, Specht P, Moll G, VAN Woensel J, van der Loos C . Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol. 2011; 225(4):618-27. DOI: 10.1002/path.2987. View

Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P . Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012; 7(4):e35876. PMC: 3340400. DOI: 10.1371/journal.pone.0035876. View

Halpin D, Faner R, Sibila O, Badia J, Agusti A . Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?. Lancet Respir Med. 2020; 8(5):436-438. PMC: 7270536. DOI: 10.1016/S2213-2600(20)30167-3. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N . TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. J Virol. 2019; 93(6). PMC: 6401451. DOI: 10.1128/JVI.01815-18. View

10.

Zhang J, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y . Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75(7):1730-1741. DOI: 10.1111/all.14238. View

11.

Jackson D, Busse W, Bacharier L, Kattan M, OConnor G, Wood R . Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146(1):203-206.e3. PMC: 7175851. DOI: 10.1016/j.jaci.2020.04.009. View

12.

Magalhaes G, Rodrigues-Machado M, Motta-Santos D, Silva A, Caliari M, Prata L . Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol. 2015; 172(9):2330-42. PMC: 4403097. DOI: 10.1111/bph.13057. View

13.

Dougherty R, Sidhu S, Raman K, Solon M, Solberg O, Caughey G . Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol. 2010; 125(5):1046-1053.e8. PMC: 2918406. DOI: 10.1016/j.jaci.2010.03.003. View

14.

Limburg H, Harbig A, Bestle D, Stein D, Moulton H, Jaeger J . TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes. J Virol. 2019; 93(21). PMC: 6803253. DOI: 10.1128/JVI.00649-19. View

15.

Woodruff P, Boushey H, Dolganov G, Barker C, Yang Y, Donnelly S . Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A. 2007; 104(40):15858-63. PMC: 2000427. DOI: 10.1073/pnas.0707413104. View

16.

Garg S, Kim L, Whitaker M, OHalloran A, Cummings C, Holstein R . Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):458-464. PMC: 7755063. DOI: 10.15585/mmwr.mm6915e3. View

17.

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W . The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells. J Virol. 2020; 95(1). PMC: 7737752. DOI: 10.1128/JVI.01648-20. View

18.

Bertram S, Glowacka I, Blazejewska P, Soilleux E, Allen P, Danisch S . TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol. 2010; 84(19):10016-25. PMC: 2937781. DOI: 10.1128/JVI.00239-10. View

19.

Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S . 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27. PMC: 7102618. DOI: 10.1016/j.jgar.2020.02.021. View

20.

Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pohlmann S . Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A. 2005; 102(22):7988-93. PMC: 1142358. DOI: 10.1073/pnas.0409465102. View